Considerations of antiviral treatment to interrupt mother-to-child transmission of hepatitis B virus in China
Author(s) -
Fuqiang Cui,
Joseph Woodring,
Polin Chan,
Fujie Xu
Publication year - 2018
Publication title -
international journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.406
H-Index - 208
eISSN - 1464-3685
pISSN - 0300-5771
DOI - 10.1093/ije/dyy077
Subject(s) - medicine , hbsag , hbeag , hepatitis b virus , transmission (telecommunications) , viral load , hepatitis b , virology , pediatrics , immunology , virus , electrical engineering , engineering
Treating high-risk women with antivirals in their third trimester is a promising intervention to further reduce perinatal transmission in neonates born to hepatitis B surface antigen positive [HBsAg(+)] mothers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom